The mammalian high-mobility group I (HMGI) family of chromosomal proteins includes HMG-I and HMG-Y, which are coded for by the same gene, HMGI(Y), through alternative splicing (23) , and the closely related HMGI-C protein (27) . The HMGI proteins are involved in the regulation of chromatin structure and function (25) . While not typical transcriptional activators, HMGI(Y) proteins are required for the expression of many eukaryotic genes. These proteins bind adenine-and thymine-containing sequences located in the minor groove of DNA. Their DNA-binding domain is located in the N-terminal region of the protein and contains three short basic repeats, the so-called AT hooks. HMGI(Y) DNA-binding sites have been identified in many promoters, e.g., interleukin-4 (13), interleukin-2 receptor ␣-chain (22) , lymphotoxin (15) , and the human papovavirus JC (24) genes. These sites are often close to the DNA-binding sites of known transcription factors like NF-B (38) and Tst-1/Oct-6 (24) and appear critical for viral induction of the human beta interferon gene (14, 38, 39) . HMGI(Y) also interacts directly with several transcription factors. In fact, it binds to the basic leucine zipper region of the activating transcription factor 2, thus promoting its dimerization and binding to the beta interferon promoter (14) .
HMGI-C gene knockout mice show a pygmy phenotype with a reduction of the adult body weight, mainly affecting fat tissue (49) . The fat index, a reliable indicator of the total fat content relative to body weight, is approximately eight times lower in pygmy mice than in the wild-type littermates. Furthermore, the regulation of HMGI-C in vivo modulates obesity in a mouse model, and rearrangements of the HMGI-C and the HMGI(Y) genes have been found in human lipomas carrying chromosomal translocations involving the regions 12q13-14 and 6p21, respectively (2, 34, 40) . Our group has recently demonstrated that the HMGI-C rearrangement plays a critical role in the generation of lipomas. In fact, transgenic mice carrying a truncated HMGI-C gene, which contains only the three AT hook domains, develop a giant phenotype and predominantly abdominal and pelvic lipomatosis (4) . These observations, taken together, implicated HMGI(Y) proteins in adipogenesis. To elucidate further the mechanism of action of HMGI(Y) in adipogenesis, we used mouse 3T3-L1 fibroblasts as a model system. These cells differentiate into adipocytes upon treatment with specific agents (35) . Adipocyte differentiation involves a group of transcription factors, CCAAT/enhancer-binding proteins (C/EBPs) (5, 29, 33, 42, 46) , which are expressed at specific stages of adipogenesis. Hormonal stimulation causes C/EBP␤ and C/EBP␦ levels to increase and induce the expression of the transcription factor peroxisome proliferator-activated receptor gamma (44) . This factor, in turn, leads to an increase of C/EBP␣, which promotes the Cetus, Branchburg, N.J.). The PCR amplification was performed for 30 cycles (94°C for 30 s, 55°C for 2 min, and 72°C for 2 min). The primers used for aP2 gene expression were 5Ј-GATGTCAGCAGGAAGTCACC-3Ј and 3Ј-CGAAG GAGGTTTAGCAAGAG-5Ј, corresponding to nucleotides 109 to 138 and nucleotides 427 to 408 (41) . For the obese gene expression the sequences of the primers used were 5Ј-CCTGCTCCAGCAGCTGCAAG-3Ј and 5Ј-GAGGAAA ATGTGCTGGAGACCC-3Ј, which map on exon 1 and exon 2, respectively, and give rise to a specific 195-bp product (20) . In addition, a set of primers specific for GAPDH was added to each reaction after 20 cycles of PCR to serve as an internal control for the amount of cDNA tested. The GAPDH-specific primers were the following: 5Ј-ACATGTTCCAATATGATTCC-3Ј (forward), corresponding to nucleotides 194 to 214, and 5Ј-TGGACTCCACGACGTACTCA G-3Ј (reverse), corresponding to nucleotides 336 to 356. The reaction products were analyzed on a 2% agarose gel and then transferred by blotting to GeneScreen Plus nylon membranes (Dupont, Boston, Mass.). The membranes were hybridized with an HMGI(Y) cDNA probe (7, 23) . The relative levels of aP2 and ob expression were assessed by comparison with the level of GAPDH in the same sample.
Immunoblotting and immunoprecipitation. Protein extracts were prepared from terminally differentiated or undifferentiated fibroblasts as previously described (6) . The following antibodies were used for immunoprecipitation and Western blotting: anti-C/EBP␤ (C-19) rabbit polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, Calif.) and anti-HA 12CA5 mouse monoclonal antibodies (Boehringer, Mannheim, Germany). The rabbit polyclonal antibodies directed against the HMGI(Y) proteins already have been described (7, 8) . For Western blot experiments, equal amounts of protein lysates were loaded, as demonstrated by staining of the membranes with Ponceau Red. To confirm equal loading, the same Western blots were incubated with antibodies to ␥-tubulin (Sigma-Aldrich Corporation, St. Louis, Mo.). For coimmunoprecipitation experiments, antigens and antibodies were incubated for 1 h before the addition of protein A-Sepharose beads (Pharmacia Biotech, Uppsala, Sweden). After another 1 h, the beads were collected and washed five times with lysis buffer. The beads were then boiled in sodium dodecyl sulfate (SDS) loading buffer for immunoblotting analysis. The protein extracts separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) were transferred to Immobilon-P transfer membranes (Millipore). Membranes were blocked with 5% nonfat milk proteins and incubated with antibodies at the appropriate dilutions. Bound antibodies were detected by the appropriate horseradish peroxidase-conjugated secondary antibodies followed by enhanced chemiluminescence (Amersham).
In vitro and in vivo binding assays. For in vitro binding assays, the HMGI(Y) cDNA was expressed as a glutathione S-transferase (GST) fusion protein in bacteria as described previously (10) . Briefly, a 900-bp EcoRI-BamHI fragment generated by PCR and including the complete coding sequence was subcloned in pGEX2T. The GST-HMGI(Y) construct was used to transform Escherichia coli strain BL21. Bacterially expressed GST and GST-HMGI(Y) proteins were bound to glutathione-agarose (Sigma-Aldrich Corporation). The beads were washed, and the size and purity of the bound protein were evaluated by Coomassie staining of an SDS-polyacrylamide gel. Equal amounts of GST and GST-HMGI(Y) proteins (5 g) were used for binding assays. C/EBP␤ cDNA was obtained by PCR amplification and cloned in the pBluescript vector (Stratagene, La Jolla, Calif.). Transcription and translation reactions were performed with the T7-rabbit reticulocyte lysate kit (Promega, Madison, Wis.) as suggested by the manufacturer. The in vitro-translated C/EBP␤ was allowed to associate with glutathione-agarose-bound GST or GST-HMGI(Y) for 2 h in lysis buffer (6) at 4°C. The pellets were washed four times in lysis buffer, and the proteins were dissociated by boiling in loading buffer and electrophoresed on a 10% polyacrylamide-SDS gel. The proteins were transferred to Immobilon-P, and C/EBP␤ was visualized as described above. For in vivo binding assays, 293 cells were transfected as described by Graham and van der Eb (18) . Cells were transfected with 5 g of each plasmid, and carrier DNA was added to a total of 10 g. Cells were harvested 36 h after transfection, and protein extracts were prepared as described above. Extracts were immunoprecipitated and immunoblotted with the indicated antibodies.
Transient transfection and luciferase activity assay. Transfections into 293 cells were performed by calcium phosphate precipitation (18) . Cells were transfected with 5 g of p(Ϫ161)ob-luc, m52, or RSV-luc reporter plasmids together with 1 g of pHMGI(Y)s. The hemagglutinin (HA)-tagged HMGI(Y) wild-type and deletion mutants were generated by PCR, sequenced, and subcloned into the pCEFL vector. One microgram of pSV2CAT plasmid was cotransfected to demonstrate equal transfection efficiency in the cell lines tested, and chloramphenicol acetyltransferase activity was measured by thin-layer chromatography with 95% chloroform-5% methanol. Cells were harvested 24 h after transfection, and luciferase activity was measured with a luminometer (Lumat LB9507; Berthold).
The relative activities were calculated by dividing the normalized activities by the activity of the m52 and the Rous sarcoma virus constructs, which were considered to be equal to 1. The data represent the average of results from three independent experiments, performed in duplicate, with standard deviations.
RESULTS
3T3-L1 adipocytic differentiation is associated with an increase in HMGI(Y) protein levels. We first investigated whether the expression of HMGI(Y) was regulated during adipocyte differentiation. As a model system, we used the 3T3-L1 preadipocytic cells, which have been extensively characterized. These cells undergo adipocytic conversion upon exposure to fetal bovine serum and differentiating agents (dexamethasone, methylisobutylxanthine, and insulin), as previously described (35) . Cells were harvested in growing, undifferentiated conditions, at time zero (2 days postconfluence), and at different times during differentiation, and RNAs and proteins were prepared. Northern blot analysis showed that endogenous HMGI(Y) is expressed at low levels in growing cells, and it increases at time zero. It reaches its maximal level between 6 h and day 1 of treatment with differentiating agents and decreases again at day 4 ( Fig. 1A) , suggesting that the expression of HMGI(Y) is regulated, during differentiation, at the mRNA level. Western blot analysis showed a parallel increase of the HMGI(Y)-gene-specific protein product (Fig. 1B) . growth arrest and the coordinated expression of adipocytespecific genes. Among these transcription factors, C/EBP proteins play a critical role in the development of the adipocyte differentiation program. Indeed, the levels of the C/EBP proteins increase during adipocyte differentiation. The increase of C/EBP␤ and C/EBP␦ occurs early during differentiation and is followed by the increase of C/EBP␣, which ultimately controls the expression of several genes, among which are the genes for aP2 and leptin (26) . Our data indicated that HMGI(Y) proteins are also required for differentiation of 3T3-L1 preadipocytes. These observations suggested that HMGI(Y) might influence adipocytic differentiation through interactions with the C/EBP transcription factors. To test this hypothesis, 3T3-L1 cells were synchronously differentiated into adipocytes by hormonal treatment. Cells were harvested at time zero and at various times during differentiation, and the interaction between C/EBP␤ and HMGI(Y) was examined by coimmunoprecipitation experiments. Protein extracts were immunoprecipitated with anti-C/EBP␤ antisera and immunoblotted with anti-HMGI(Y) antibodies (Fig. 5A, upper panel) . Interaction between C/EBP␤ and HMGI(Y) was detected at time zero; it increased at 6 h and remained stable until day 6 of differenti- ation. This interaction was not detected when a preimmune serum was used for lysate extracts of 6 h (Fig. 5A) . In agreement with previous observations, C/EBP␤ levels increased during early differentiation of 3T3-L1 cells (Fig. 5A, lower panel) . We also detected binding of HMGI(Y) and the other two C/EBP proteins (not shown); these interactions occurred with different kinetics.
To verify these interactions, we carried out in vitro and in vivo binding studies with C/EBP␤ and HMGI(Y). C/EBP␤ was synthesized in vitro by using rabbit reticulocyte lysates, and HMGI(Y) was produced as a GST fusion protein and bound to glutathione-agarose beads (GST-Y). A pull-down assay was performed by incubating the two proteins. GST-bound proteins were immunoblotted on Immobilon-P and detected with anti-C/EBP␤ antibodies. As shown in Fig. 5B , GST-Y, but not GST, was able to coprecipitate with C/EBP␤. For the in vivo binding assays, the plasmids encoding C/EBP␤ and HMGI(Y) were transiently transfected in 293 cells. The cDNA encoding C/EBP␤ was expressed in the 293 cells alone and with HA-HMGI(Y). Cell extracts were immunoprecipitated with anti-C/EBP␤ or with anti-HMGI(Y) antibodies and immunoblotted with the reciprocal antisera. Coexpression of C-EBP␤ and HMGI(Y) resulted in reciprocal coimmunoprecipitation of the two proteins (Fig. 5C) . Analogous results were obtained by using C/EBP␣ and C/EBP␦, which also bound to HMGI(Y) in vivo and in vitro (data not shown).
Mapping of the HMGI(Y) region responsible for binding to C/EBP␤. To map the HMGI(Y) region required for binding to C/EBP␤, we generated a series of progressive deletions of the HMGI(Y) gene in an area corresponding to the carboxy-terminal region of its product (Fig. 6A) . The resulting cDNAs were tagged with the influenza virus HA epitope and cloned into the pCEFL expression vector. Immunoblotting analysis showed that approximately equal amounts of wild-type and mutant proteins were produced. These mutants were tested for their interaction in vivo with C/EBP␤ in coimmunoprecipitation experiments. Each HMGI(Y) plasmid was transfected in 293 cells together with a C/EBP␤-expressing vector. Thirty-six hours after transfection, cells were harvested and protein extracts were immunoprecipitated with anti-C/EBP␤ antibodies. As shown in 
HMGI(Y) cooperates with C/EBP in the regulation of the obese gene promoter, a C/EBP-regulated gene.
The foregoing results suggested that C/EBP␤ cooperates with HMGI(Y) in the activation and/or repression of adipocyte-specific gene promoters. We focused on the promoter of the leptin protein, encoded by the obese gene, since its expression during adipocytic induction seems to depend on HMGI(Y) synthesis. We first used the obese (ob) minimal promoter (Ϫ161), which contains C/EBP motifs and which is a natural target of C/EBP transcription factors (20, 28) . A plasmid containing the ob minimal promoter fused to the luciferase reporter gene (Ϫ161 ob-luc) was transfected in 293 cells with or without C/EBP␤. As shown in Fig. 7A , C/EBP␤ activated luciferase transcription. When C/EBP␤ was cotransfected with HMGI(Y), activation of the ob promoter was significantly potentiated. Conversely, no activation was observed in the presence of HMGI (Y) alone or when the m52-ob-luc promoter, which is mutated in the C/EBP-binding site, was used for the cooperativity assay. Analogous results were obtained when we used the ob-luc-762 long promoter (data not shown). As a further control for the specificity of the stimulatory effect of HMGI(Y) on C/EBPmediated transactivating activity, we used another reporter vector, RSV-luc. This vector contains a promoter which has a low basal activity in 293 cells and is insensitive to C/EBP. As shown in Fig. 7B , neither C/EBP␤ or HMGI(Y) alone nor the combination of the two proteins was able to significantly stimulate this promoter. Moreover, we have demonstrated that HMGI(Y) is also able to cooperate with C/EBP␣ in the transactivation of the leptin promoter (data not shown).
We then asked whether physical interaction between HMGI (Y) and C/EBP␤ was important for the potentiation of leptin transcription. We tested the HMGI(Y) deletion mutant 1-63, which is still able to bind C/EBP␤, and the mutants 1-53 and 1-43 (Fig. 7A) , which are defective in binding C/EBP␤, for their ability to activate the ob-luc promoter in the presence of C/EBP␤. As shown in Fig. 7A , mutant 1-63 behaved like wildtype HMGI(Y) in the C/EBP␤-mediated transactivation assay. When mutant 1-53 was used, there was a significant (more than 50%) reduction of activity in the cooperativity assay. When we used mutant 1-43, the effect was more dramatic, i.e., a sixfold loss of activity. These results suggest that deletion of residues 54 to 63, which are important for interaction between HMGI (Y) and C/EBP␤, partially impairs their functional cooperation. The more dramatic phenotype observed with the 1-43 mutant, which also lacks the second basic repeat of HMGI(Y), suggests that the HMGI(Y) 43-to-53 region mediates the activation of the leptin promoter independently from its ability to bind C/EBP. Western blot analysis showed that the transfected cells expressed adequate levels of the C/EBP␤ and HMGI(Y) proteins (Fig. 7C) .
DISCUSSION

Adipocytic differentiation requires HMGI(Y). HMGI(Y)
and HMGI-C proteins are important architectural transcription factors (19) , and a growing body of evidence suggests that they are involved in adipocytic differentiation (2, 34, 40, 49) . We have investigated the role of HMGI(Y) proteins in adipogenesis using 3T3-L1 preadipocytic cells as a model system. Northern and Western blot analyses demonstrated induction of the HMGI(Y) gene and protein when 3T3-L1 cells were induced to differentiate into adipocytes. HMGI(Y) expression is detectable at very low levels in growing, undifferentiated 3T3-L1 cells and increases during differentiation. These observations suggested that an increase in HMGI(Y) levels is necessary for 3T3-L1 differentiation. Indeed, suppression of HMGI(Y) protein synthesis through antisense methodology prevented terminal adipocytic differentiation. Not only did these cells not show the typical fat-laden phenotype, but they also lacked the expression of two adipocytic markers, aP2 and leptin. On the other hand, forced expression of the HMGI(Y) gene resulted in inhibition of growth, but it was not able to The relative activities were calculated by dividing the normalized activities by the activity of the m52 and RSV-luc constructs, which has been considered equal to 1. The data represent the average of results of three independent experiments, performed in duplicate, with standard deviations. (C) After transfection, cell lysates were divided into two aliquots. One of these aliquots was used for transactivation assays, and the other was used for Western blot analysis as a control of protein expression. Protein extracts were separated by SDS-PAGE, transferred to Immobilon-P, and immunoblotted with the indicated antibodies.
induce differentiation. These data demonstrated that the wildtype HMGI(Y) protein is required, but not sufficient, for 3T3-L1 cells to differentiate into adipocytes. Three members of the C/EBP family of transcription factors (C/EBP␣, -␤, and -␦) have been implicated in the induction of adipocyte differentiation. In particular, overexpression of C/EBP␣ is sufficient to arrest growth and to start the adipocyte differentiation program in preadipocytic cell lines (26) . Recent data obtained in our laboratory indicate that its forced expression in the 3T3-L1 HMGI(Y)as cells is not able to revert their phenotype, i.e., the block of growth arrest and adipocytic differentiation (data not shown). These data indicate that HMGI(Y) is indeed necessary for C/EBP␣ to induce its biological effects. This hypothesis is also supported by results of other experiments. The promoters of several adipocyte-specific genes contain C/EBP regulatory binding sites. For instance, C/EBP␣ was shown to bind and transactivate the aP2 promoter. Furthermore, the leptin promoter contains at least one functional C/EBP binding site: disruption of this consensus sequence by site-directed mutagenesis causes a remarkable decrease in promoter activity (20, 28) . Based on these observations, we argued that HMGI (Y) modulates the transcriptional activity of the C/EBPs. This hypothesis was confirmed by the finding that HMGI(Y) physically interacts with C/EBP transcription factors.
HMGI(Y) proteins suppress 3T3-L1 cell proliferation. In 3T3-L1 cells undergoing adipocyte differentiation, there is a G 1 /G 0 arrest at confluence, followed by a phase of clonal expansion initiated by the differentiating agents (26) and a subsequent arrest about 2 days later. We show that suppression of HMGI(Y) expression causes a blockage in the differentiation associated with an increased growth rate in 3T3-L1 cells. Furthermore, treatment of HMGI(Y) antisense-expressing cells with differentiating agents failed to induce the cell cycle arrest that precedes differentiation. Therefore, we suggest that HMGI(Y) plays a critical role in adipocytic cell growth. The levels of HMGI(Y) do not correlate with the cell cycle status of the cells during induction of differentiation, being highest in the phase of mitotic clonal expansion (6 h and day 1) and reduced in growth-arrested, differentiating cells (days 0 and 4). This paradox could be explained by the fact that HMGI (Y) is an accessory protein, with multiple functions, for a wide range of transcription factors. Its effect could enhance growth arrest or proliferation depending on the presence of different transcription factors.
Our data indicate that the role of HMGI(Y) in the control of adipocytic cell growth counteracts that of HMGI-C. In fact, while overexpression of HMGI(Y) negatively regulates adipocytic cell growth, HMGI-C expression seems to be necessary for physiological proliferation of adipocytes. Indeed, HMGI-C knockout mice display a pygmy phenotype with a remarkable reduction of the adipose tissue (49) , and the suppression of the HMGI-C synthesis blocks proliferation of the 3T3-L1 cells (S. Battista et al., unpublished data). We suggest that the growth of adipocytic cells results from the balance between levels of HMGI-C and HMGI(Y). From the data presented here, the role of HMGI(Y) seems to be pleiotropic, depending on the cellular context. HMGI(Y) proteins often have been associated with cell proliferation: in fact, HMGI(Y) has been found overexpressed in several experimental and human malignant tumors (1, 3, 8, 9, 16, 17, 36) We also mapped the domain of HMGI(Y) that is required for its functional cooperation with C/EBP␤. Deletion of the region between the third and the second AT hook impaired the ability of HMGI(Y) to cooperate with C/EBP␤. Interestingly, this region is also required for efficient HMGI(Y) and C/EBP␤ binding, confirming that physical interaction between the two factors contributes to efficient functional cooperation. We show that a further deletion, which abrogates the second AT hook, completely abolishes the cooperation of HMGI(Y) and C/EBP␤. Consequently, the second AT hook also plays a role in the activation of the ob promoter. The cooperation between HMGI(Y) and C/EBP in the transactivation of the leptin promoter could be explained by several mechanisms, which are not mutually exclusive. One possibility is that the binding of HMGI(Y) to C/EBP could enhance the affinity of C/EBP for its target DNA. Such a mechanism has been demonstrated for other transcription factors, such as NF-B (47). Alternatively, HMGI(Y) could recruit one or more components of the basal transcriptional machinery to the protein-DNA complexes, thus enhancing transcription. Whatever the mechanism, proteinprotein interaction between HMGI(Y) and C/EBP␤ might favor the activity of the C/EBP transcriptional complex. However, our data seem also to indicate that there is only a partial contribution of this interaction to the cooperation between HMGI(Y) and C/EBP␤ in transactivating the leptin promoter. This suggests that other functions, dependent on HMGI(Y) residues 43 to 53, are important for this cooperation.
Furthermore, preliminary data obtained in our laboratory show that HMGI(Y) and C/EBP␤ negatively regulate the promoter of the Id1 gene, whose expression is down-regulated during adipogenesis and correlates with growth arrest that precedes differentiation (30, 31) .
Conclusions. The data presented here show that HMGI(Y) exerts a negative effect on the proliferation of adipocyte precursors and a positive effect on differentiation. This dual role is consistent with the finding that HMGI proteins may positively and negatively affect gene expression. We also demonstrate that the HMGI(Y) protein physically interacts with C/EBP proteins and that it functionally cooperates in the transcriptional activity mediated by these proteins, whose function is required to trigger the expression of adipocyte-specific genes.
